Table 2b Response rate analyses for use of combination vs single agent regimens in the first-line settings
From: Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review
Model A mean ORR (95% confidence interval) | P -value | Model A weighted ORR | Model B (95% confidence interval) | P -value | |
|---|---|---|---|---|---|
First-line combination | 61.8 (53.5–70.1) | <0.001 | 63.5 | 61.8 (54.6–69.1) | <0.001 |
First-line single agent | 26.8 (14.2–39.4) | 24.3 | 26.8 (22.2–61.4) |
